Dr.A. Sreenivas Kumar

Dr.A. Sreenivas Kumar
Cardiologist, Hyderabad

MBBS, MD, DM, FACC (USA)

Dr. A. Sreenivas Kumar is the chairman and chief Cardiologist in Cardiovascular sciences, at Citizens Hospitals, Hyderabad. He is the most renowned Cardiologist at National & International Levels. He has enormous expertise in the fields of Coronary Interventions, Mitral Balloon Valvotomy and Structural Heart Interventions. Dr. A. Sreenivas Kumar has had the privilege of training many young Interventional Fellows from India, Burma, Nepal, Africa, Sweden and USA.
  • Languages :English, Hindi, Telugu

Specialities

  • Cardiology

  • Interventional Cardiology

  • Cardiovascular Surgery

Expertise

Education

MBBS, 1989, Osmania Medical College, Hyderabad

MD (Gen. Med.), 1994, Osmania Medical College, Hyderabad

DM (Cardiology), 1998, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow

FACC (USA), 2008, Chicago

Practice Information

Citizens Hospital, Hyderabad

Citizens Hospital, Hyderabad

Nallagandla, Serilingampally, Hyderabad, Telangana - 500019

MON - SAT

10:00 AM - 04:00 PM

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr.A. Sreenivas Kumar and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Faculty for SING LIVE Course in Singapore in 2006-08
  • Faculty for CIT- China Interventional Therapeutics-2009
  • Faculty for CCT-Kobe, Japan-2009
  • Faculty for Angioplasty Summit, Seol, Korea-2010
  • Faculty for TCT,USA -2011,2012
  • Live Case Operator for Procedure Demonstration to TCT,USA 2012
  • Principal investigator for Nephric – II Study – A Randomized Comparison of Iapamiro vs. Iopamidal in Diabetic Renal Insufficiency patients- Sponsored by GE Health Care. – Appreciated as World’s leading recruiter for enrolling maximum no of patients
  • Co-investigator - a multinational, multicentre, randomized, parallel group, Double-blind study to assess the efficacy and safety of 1 mg, 5 Mg and 20 mg tid of oral sildenafil in the treatment of Subjects aged 18 years and over with pulmonary arterial Hypertension (PAH)- A Multicentre PAH study sponsored by Pfizer Int. Ltd.- Leading recruiters in the world
  • Principal investigator - Spirit women clinical evaluation: A Clinical Evaluation of the Xience - V Everolimus eluting coronary stent system in the treatment of women with denovo coronary artery lesion (single arm study protocol) – Leading recruiter in the world
  • Pricipal investigator – AMI - Stem cell study – A Randomized, double blind Multicentric, Placebo controlled, Single dose , Phase-II Study assessing the safety and efficacy of Intravenous ex vivo cultured adult allogenic mesenchymal stem cells in patients with STEMI.- Sponsored by Stempeutics Research Ltd
  • Co-investigator - Art (Arterial Revascularisation Trial)
  • Art is a multi-centre, international, randomized trial evaluating whether the use of both mammary arteries during coronary artery bypass grafting (CABG) improves survival, and reduces the chance of recurrent chest pain and/or the need for further intervention (including surgery) compared to using one mammary artery. ART is supported by grants from the Medical Research Council and the British Heart Foundation
  • National Lead Investigator – Msure –Sirolimus Eluting Co. Chromium Stent – Clinical & Angiographic Follow up Study
  • S. R. Rao Research Award for best thesis in M. D. General Medicine “A study of clinical profile of cases of Sickle cell disorder in adults”
  • PRINCIPAL INVESTIGATOR for Nephric – II Study – A Randomized Comparison of Iapamiro vs. Iopamidal in Diabetic Renal Insufficiency patients- Sponsored by GE Health Care. – Appreciated as World’s leading recruiter for enrolling maximum no of patients
  • CO-INVESTIGATOR - a multinational, multicentre, randomized, parallel group, Double-blind study to assess the efficacy and safety of 1 mg, 5 Mg and 20 mg tid of oral sildenafil in the treatment of Subjects aged 18 years and over with pulmonary arterial Hypertension (PAH)- A Multicentre PAH study sponsored by Pfizer Int. Ltd.- Leading recruiters in the world
  • PRINCIPAL INVESTIGATOR - SPIRIT WOMEN CLINICAL EVALUATION: A Clinical Evaluation of the Xience - V Everolimus eluting coronary stent system in the treatment of women with denovo coronary artery lesion (single arm study protocol) – Leading recruiter in the world
  • PRICIPAL INVESTIGATOR – AMI - Stem cell study – A Randomized, double blind Multicentric, Placebo controlled, Single dose , Phase-II Study assessing the safety and efficacy of Intravenous ex vivo cultured adult allogenic mesenchymal stem cells in patients with STEMI.- Sponsored by STEMPEUTICS Research Ltd
  • CO-INVESTIGATOR - ART (Arterial Revascularisation Trial)ART is a multi-centre, international, randomized trial evaluating whether the use of both mammary arteries during coronary artery bypass grafting (CABG) improves survival, and reduces the chance of recurrent chest pain and/or the need for further intervention (including surgery) compared to using one mammary artery. ART is supported by grants from the Medical Research Council and the British Heart Foundation
  • National Lead Investigator – Msure –Sirolimus Eluting Co. Chromium Stent – Clinical & Angiographic Follow up Study
  • Influence of Subvalvular pathology on immediate results and follow up events of Inoue balloon mitral valvotomy.
  • Small aortic annulus: A Functional definition. Annals of Asian cardiovascular and thoracic surgery October 98.
  • Periodic Intermittent Electromechanical Dissociation: Hemodynamic Correlate of a Malfunctioning Mechanical Prostheses Letter to the Ed. Cath Cardiovasc. Diagn. Nov.97.
  • Results of Inoue balloon mitral valvotomy in juvenile rheumatic mitral stenosis. Let. to Ed. Int. J. Cardiol. 1998,66: 97-98.
  • Percutaneous closure of the ductus by controlled release coils. Asian Annals of Cardiovascular and thoracic sugery.
  • Angiographic sizing of the patent ductus arteriosus - Relevance in the coil era. Int Journal of Cardiol.
  • Inoue balloon mitral commissurotomy (IBMC) in patients with atrial septal aneurysm (ASA). Int. Journal Of Cardiology2001.
  • Endovascular stenting of the obstructed vertical vein in a neonate with supracardiac total anomalous pulmonary venous return Annals of Paediatric Cardiology 2012.
  • Non-invasive evaluation of Coronory flow collaterals- An echo and angio correlation American Society of Echocardiography June 2008
  • Nephrotoxicity of Iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures – Warren Lasky, Peter Aspelin, Charles Davidson Am.Heart Journal 2009;158.
  • Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects in Children with the Amplatzer Duct Occluder II Device. Journal of the American College of Cardiology, Volume 60, Issue 23, 11 December 2012, 2421-2422
  • Scientific Advisory Member - Indian Heart Journal
  • Founder Editor of National Medical Journal “Post Graduate Medical Clinics of Osmania’’
  • President for 2009-10, Cardiological Society of India, AP Chapter
  • Executive Committee member, Cardiological Society of India 2007-09